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ORAL CONTRACEPTIVES AND EXERCISE1
RICHARD A. MOSTARDI, NANCY R. WOEBKENBERG, and MARCIA T. JARRETT, De-
partment of Biology, The University of Akron, Akron, OH 44325
Abstract. Twelve college women, 5 naturally cycling and 7 on oral contraceptives,
participated in a study to determine if oral contraceptives have an effect on selected
hematologic and metabolic variables. The women worked at 2 workloads on a bicycle
ergometer: 50% and 90% of their maximal aerobic capacity during 3 phases of the
menstrual cycle, post mensus, ovulation, and mid-luteal. Within group differences
were examined to determine if one time of the month was more suitable for doing sub-
maximal or near maximal work, and between group differences were examined to de-
termine the effects of oral contraceptives. Within the 2 groups, there were no sig-
nificant differences for any variables. Between group differences were associated with
higher heart rate and ventilation values for the women on oral contraceptives when
the workloads were near maximal.
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Physiological variations associated with
the naturally cycling female menstrual
cycle have been well documented in the
literature. Performance, mental outlook,
and blood variables have been extensively
studied (Curtis-Prior et al 1974, Dalton
1960, Gamberale et al 1975, Garlick and
Bernauer, Doolittle and Engebretsen
1972), but the results are not entirely
clear since some authors have reported
changes in blood and metabolic factors
while others maintain that physiological
variations during the menstrual cycle are
slight, if any at all.
Lacking in the literature are any values
for oxygen consumption (Vo2), ventila-
tion (VE), and heart rate during steady
state or near maximal levels of exercise
in women taking oral contraceptives.
The present study compares the relative
metabolic, ventilatory, and blood factors
of 12 women to determine how these
factors were affected in subjects using
oral contraceptives.
METHODS AND MATERIALS
Twelve college women (ages 20-25) gave their
informed consent and volunteered for this
study. All were given examinations by their
family physician, who had been previously in-
formed regarding the nature of the study.
The subjects were in good health, and none
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was participating in endurance sports. Vital
data for the 2 groups appear in table 1.
Each subject reported to the laboratory for
an explanation of the study, familiarization
wi-th the bicycle ergometer and mouthpiece
(Warren E. Collins Triple J), and to ride several
workloads of low intensity (>25% of maximal
arobic capacity). On the second visit to the
laboratory, 2 more rides were carried out with
the second ride calculated to approximate the
subject's maximal aerobic capacity. If the
subject was able to complete that ride, she re-
turned on another day for another maximal ef-
fort. When the subject could no longer main-
tain the pedal frequency (60 revolutions per
minute) or when values for Vo2 were within 1%
for two rides, maximal aerobic power was as-
sumed to have been achieved. During the
last minute of each ride, values for Vo2, heart
rate, and VE were determined. Inspired vol-
umes were calculated using a Parkinson Cowan
CD 4 dry gas meter, and expired volumes were
collected in Douglas bags. Oxygen was an-
alyzed in a Beckman E2 oxygen analyzer, and
carbon dioxide in a Beckman-Spinco LB-1 CO2
analyzer. Both were carefully calibrated with
analyzed gases. Heart rate was recorded on
a Hewlett Packard electrocardiograph Model
1500A.
The subjects reported to the laboratory 3
times a month for 3 consecutive months or until
3 months of data were completed. The 3
monthly visits corresponded to their particular
monthly cycle and coincided to the following:
termination of mensus, ovulation, and mid-
luteal phases. The naturally cycling women
used a rise in oral temperature as an indication
of ovulation. In the women taking.the con-
traceptives, the ovulatory phase was estimated
as the mid-point in the cycle. In both groups,
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mid-luteal was estimated as a day midway
between ovulation and the onset of the next
mensus. All of the women on the pill had reg-
ular mensus and mid-luteal estimations were
made with relative confidence. Each subject
was in almost daily contact with the staff, and
the day immediately following mensus or fol-
lowing a temperature rise in the naturally
cycling women, the subject reported to the
laboratory. All rides were carried out at the
same time of day for each phase of the menstrual
cycle.
During a typical experimental ride, subjects
adhered to the following procedures. In each
group, 4 subjects consented to have blood
drawn, and the first procedure was to withdraw
10 ml of blood from an anticubital vein. While
seated on the bicycle ergometer, the subject's
resting heart rate and blood pressure (BP)
were recorded. Based on the preliminary ser-
ies of rides, two workloads representing approxi-
mately 50% and 90% of the subject's maximal
aerobic capacity were selected, and each sub-ject rode these two workloads for 5 minutes with
10 minutes of rest between rides. The pre-
viously mentioned metabolic and ventilatory
variables were measured during the last minute
of each of these rides.
The red blood count (RBC), white blood
count (WBC), hemoglobin (Hb), hematocrit
(Hct), and red blood cell indices were deter-
mined on a Coulter Counter (Model S). Blood
urea nitrogen (BUN), glucose, sodium (Na+),
potassium (K+), and chloride (Cl~) were de-
termined on a Technicon (SMA 6/60). The
serum creatine phosphokinase (CPK) was
analyzed on a Gilford 300N Spectrophotometer
and Automatic Enzyme Analyzer, and cho-
lesterol was determined manually utilizing
Hycel Cholesterol Reagent. A differential
leukocyte count was determined from a blood
smear made at the time of venipuncture. The
smear was stained with Wright's stain, and
100 white cells were differentially counted and
converted to a percentage of the total leukocyte
count.
All statistical procedures for the between
group comparisons were calculated using a
nested analysis of variance model, and within
group comparisons were made using a one-way
analysis of variance.
RESULTS AND DISCUSSION
Initial subjective observations indi-
cated that the women rode all the rides
with relative ease, and none complained
that any specific time of the month was
more or less difficult. This important
subjective evaluation has a great deal to
do with the outcome of such a study, for
any psychological factors imposed on the
subjects could easily affect heart rate,
VE, and BP.
Between group comparisons. While
women on the oral contraceptives were
seated on the bicycle, their resting heart
rate was significantly higher (P<.01)
than normally cycling women (table 1).
As expected, there were no significant dif-
ferences between the 2 groups for Vo2 at
the 50% maximal aerobic capacity level,
but heart rate at submaximal load was
significantly higher (P<.01) for women
using oral contraceptives (fig. 1). At
the near maximal levels of aerobic capac-
ity, the naturally cycling women were
working at 89% of maximal, and the
women on oral contraceptives were work-
ing at 86% of maximal. The workloads
were 158 watts and 154 watts respec-
tively. Even though the women on oral
contraceptives were working at a slightly
lower percentage of their maximal aerobic
capacity, both their heart rate and VE
TABLE 1
Vital data for female subjects taking contraceptives as compared to naturally cycling females.
Age Ht(cm)
On Contraceptives (n = 7)
20
21
20
20
25
23
20
Mean 21 ±2**
Natural Cycle
Mean 19 ±0.6
167.5
161.0
175.2
164.0
165.0
166.0
161.9
166.6±4*
(n = 5)
163.7±5
Wt(Kg)
51.2
66.5
60.7
52.0
60.2
73.1
59.9
60.5±7.7*
60.9±ll
max Vo2
(ml/Kg-min)
32.38
29.07
34.93
35.56
27.16
27.09
30.30
30.9±2.5*
32.9±2.4
Resting
Ht rate
105.82
99.76
94.96
83.53
100.13
78.62
71.09
90.6±3**
80.7±12
Pill type
Ortho Novum 1/50 Ortho
Ovulen 28 Searle
Demulen 21 Searle
Ovral Wyeth
Ortho Novum 1/50 Ortho
Loestrin 1.5/30 Parke-Davis
Loestrin 28 Parke-Davis
*Not significant, mean±SD.
**P<.01.
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TABLE 2
Summary of comparative blood data in females taking contraceptives
and natural cycling females.
PM OV ML
Contraceptive (n = 7)
WBC/mm3 x 103
RBC/mm3 x 10°
HB gm/dl
Hct vol %
Natural Cycle (n = 5)
WBC/mm3 x 103
RBC/mm3 x 106
Hb gm/dl
Hct vol %
5.50 ±1.8*
4.65 ±0.2
13.96 ±0.5
40.83±2.J
6.64±0.9
4.(54±O.4
13.60 ±0.8
40.24±l . l
6.47±0.7
4.54±0.2
13.72±0.8
39.80±2.2
7.04±0.8
4.52±0.3
13.3(5 ±0.8
38.40±1.4
7.17 =
4.46 =
13.49=
39.00=
7.36 =
4.57 =
13.50=
39.98=
= 1.3
= 0.2
= 1.0
= 2.7
= 0.8
= 0.2
= 0.7
= 1.2
*Mean ± Standard Deviation, no significant differences between
groups. PM = post menses. OV = ovulation, ML = midleuteal.
were significantly higher (P<i)l) than
those of the naturally cycling women
under the same exercise conditions (figs.
2 and 3).
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FIGURE 1. Heart rate at approximately
50% of work load (beats/min) as a function
of time within the monthly cycle. PM =
post menses, OV = ovulation, ML = mid-
leuteal. Cumulative mean±SE from sub-jects over a 3 month period. Normally
cycling women (0) n = 5, women on oral
contraceptives (A) n = 7.
There were no significant differences
for any of the blood variables studied
between these 2 groups of women (See
table 2).
Within group comparisons for both
the naturally cycling women and the
women on oral contraceptives showed no
statistical differences for any of the blood
or metabolic variables. One obvious
trend in the blood data was the rise in
the WBC's from post mensus to mid-
luteal. This trend in the WBC data is
consistent with the work of Fish and
Friedman (1973), who showed a similar
rise. Their proposed mechanism for this
response is associated with the steroid
hormones stimulating the bone marrow
for increased production.
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FIGURE 2. Heart rate at maximal work
load (beats/min) as a function of time
within the monthly cycle. Cumulative
mean ±SE over a 3 month period with
normally cycling women (0) n = 5 riding at
89% of maximal aerobic capacity and
women on oral contraceptives (A) n = 7
working at 86% of maximal aerobic
capacity.
The between group metabolic data
demonstrate some important physiologi-
cal differences. The women on the oral
contraceptives had higher values for
heart rate and VE at a lower percentage
of maximal workloads than the women
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who were naturally cycling. These val-
ues indicate that the women on oral con-
traceptives have somewhat reduced car-
diac efficiency and are ventilating more
to carry out a given amount of work
when compared to the naturally cycling
women. Such differences were also ap-
parent for their heart rate at the 50%
rides.
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FIGURE 3. Minute ventilation ±SE (^/min)
as a function of time within a monthly
cycle. PM = post menses, OV = ovulation,
ML = midleuteal. Cumulative means over
a 3 month period with normally cycling
women (0) n = 5 riding at 86% of maxi-
mal aerobic capacity, and women on
oral contraceptives (A) n = 7 working at
86% of maximal aerobic acpacity. (BTPS
= body temperature, pressure, saturated.)
Possible explanations as to why values
for heart rate at rest and exercise were
higher in the women on oral contracep-
tives could include: 1. elevation of plasma
cortisol (Layne et al 1962), 2. total serum
thyroxin (Mishell et al 1969), 3. an in-
crease in blood viscosity (Aronson et al
1971). Cortisol and especially thyroxin
are well known to increase heart rate over
normal values, but thyroxin is calorigenic
and increases metabolic rate. No evi-
dence exists of such an increase in any
of the Vo2 data in our study.
Aronson (1971) found that a rise in
blood viscosity occured in women taking
oral contraceptives but that the rise in
viscosity was also accompanied by an in-
crease in the hematocrit. An increase
in blood viscosity could be an important
consideration in explaining the reduced
cardiac efficiency in the women on oral
contraceptives, but this explanation is
not supported by our data because we
found little difference in hematocrit level
between the 2 groups. Blood viscocity
is also a function of plasma protein con-
centration, particularly fibrinogen and
globulin. Pindyck (1970) found an
elevation of cyrofibrinogens in women
taking oral contraceptives while Menden-
hall (1970) found an increase in macro-
globulins. Both findings suggest protein
as a contributing factor for an increase
in blood viscosity and an increase in the
work of the heart.
Several limitations are inherent in our
study, particularly the small number of
subjects used as well as limited sampling
within one menstrual cycle. We at-
tempted to reduce the statistical difficul-
ties of small sample size by replicating
the experimental design over a period of
3 months. As far as sampling times
within the menstrual cycle were con-
cerned, our collection times certainly
were associated with known variations in
plasma hormone levels and, as such, meet
the purposes of the experimental design.
Within these 2 groups of women we
found little metabolic or hematologic
variation. It is fully understood that
performance during menstrual flow might
be uncomfortable, and there may be some
psychological factors which could affect
the ability to do heavy work or extended
periods of steady state work (Erdelyi
1962, Wearing et al 1972). Other than
during menstruation, we found no one
time of the month more or less conducive
for performing steady state or maximal
levels of work. It is concluded that
women taking oral contraceptives have a
tendency for increased heart rate and
VE values at near maximal levels of
work capacity and increased heart rate
at approximately 50% of aerobic capacity
when compared to women who are natur-
ally cycling.
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